Page last updated: 2024-08-21

evans blue and gemcitabine

evans blue has been researched along with gemcitabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adam, U; Bornmann, C; Esser, N; Graeser, R; Hopt, UT; Jantscheff, P; Keck, T; Massing, U; Schaechtele, C; Unger, C; von Dobschuetz, E; Ziroli, V	1

Other Studies

1 other study(ies) available for evans blue and gemcitabine

Article	Year
A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Capillary Permeability; Cell Line, Tumor; Chemistry, Pharmaceutical; Deoxycytidine; Drug Carriers; Drug Compounding; Evans Blue; Gemcitabine; Liposomes; Luciferases; Luminescence; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Permeability	2008

Article

Year

A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.

Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3

Topics: Animals; Antimetabolites, Antineoplastic; Capillary Permeability; Cell Line, Tumor; Chemistry, Pharmaceutical; Deoxycytidine; Drug Carriers; Drug Compounding; Evans Blue; Gemcitabine; Liposomes; Luciferases; Luminescence; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Permeability

2008